Jeffrey Auletta, MD
College of Medicine
Assoc Professor - Clinical
Dr. Jeffery Auletta
Jeffery Auletta, MD, is a member of the Leukemia Research Program at the OSUCCC – James. Dr. Auletta is the Director of the Pediatric Blood and Marrow Transplant Program at Nationwide Children’s Hospital, which works closely with the OSUCCC – James Cell Therapy Lab and Adult Blood and Marrow Transplant Program in clinical trial development, cell therapies and educational events.
Dr. Auletta also serves as Director of the Host Defense Program, a translational research collaboration between Nationwide Children’s Hospital and the James Cancer Hospital and Solove Research Institute, which is under the OSUCCC – James umbrella.
The Host Defense Program operates in the Divisions of Hematology/Oncology/BMT and Infectious Diseases at NCH. The program’s goal is to interrogate the immune response in the context of pathogen in immunocompromised hosts to reduce infection-related morbidity and mortality through development and use of novel therapies.
Dr. Auletta’s research includes defining immunomodulation of regenerative stromal cell therapies and manipulating immune functional recovery after hematopoietic cell transplantation. His clinical research focuses on optimizing immune-directed cellular therapies for graft-versus-host disease, disease relapse, and infection as well as advancing novel antimicrobial therapies to treat infectious effects in immunocompromised patients.
Dr. Auletta has co-authored articles in well-respected journals such as Biology of Blood and Marrow Transplantation, Blood, Bone Marrow Transplantation and Pediatric Blood & Cancer. He is also a chair or co-chair on several national and international committees, including the Center for International Blood & Marrow Transplant Research (CIBMTR) and the Pediatric Blood & Marrow Transplant Consortium (PBMTC).